H214P (p.His214Pro) variant of TP53 (Cellular tumor antigen p53)
H214P (p.His214Pro) in TP53 (Cellular tumor antigen p53) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of Hereditary cancer-predisposing syndrome; Li-Fraumeni syndrome 1; Li-Fraumeni syn. The available variant effect predictions contribute to a CATVariant prioritization score of 0.84 / 1. The record also includes population frequency data, published literature, and structural context.
H214P (p.His214Pro) variant details
- p.His214Pro
- rs1057519992
- ClinGen CA397840046
- cosmic curated COSV52732
- ClinVar RCV000796697
- Uncertain significance
- Hereditary cancer-predisposing syndrome; Li-Fraumeni syndrome 1; Li-Fraumeni syn
- Missense
- Variant Prioritization Score for Impact Estimate 0.842
- REVEL 0.93
- ESM-1b 1.00
- AlphaMissense 0.82
- MetaLR 0.98
- MetaSVM 1.03
- CADD 27.60
- ClinVar: Uncertain significance (Hereditary cancer-predisposing syndrome; Li-Fraumeni syndrome 1;)
- EBI: Pathogenic (in a sporadic cancer)
- UniProt: Pathogenic (in a sporadic cancer)
- Population evidence available
- Structural context available
- Cited in: A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic… (PMID 25394175)
- Cited in: American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. (PMID 17392385)